Steven C. Gilman, Ph.D.

Steven C. Gilman, Ph.D.

DirectoratVericel· In proxies 2023–2025

Steven C. Gilman, Ph.D. sits on 6 public boards.

Boards1

  • Akebia TherapeuticsDirector · 5 yr on the boardIndependentCompensation, Research & Development—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. VericelPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role +75%
  2. Akebia TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  3. Akebia Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  4. SCYNEXIS, Inc.Public company
    • Director? – PresentNo stock prices for these years
  5. Vericel BoardPublic company
    • Director? – PresentNo stock prices for these years
  6. KeryxPublic company · 10 yr
    • Director2016 – Present · 10 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?